GBT takes a page from HIV playbook as it embarks on Oxbryta launch

13th February 2020 Uncategorised 0

The sickle cell disease market and patient support around the disease are both in the nascent stages. But Global Blood Therapeutics, a pioneer in the field with recently approved Oxbryta, sees an example to emulate as it embarks on its first launch: HIV.

More: GBT takes a page from HIV playbook as it embarks on Oxbryta launch
Source: fierce